Centenial Surgical Suture Ltd (CSURGSU) — shareholding pattern, promoter holding, financials and share price
About Centenial Surgical Suture Ltd (CSURGSU)
Centenial Surgical Suture Ltd operates in the Medical Equipment & Supplies industry, within the Healthcare sector. It trades on the NSE as CSURGSU and on the BSE under scrip code 531380. Its ISIN is INE405H01018.
Incorporated in 1995, Centenial Surgical Suture is engaged in the development, manufacturing and supply of Medical Devices. [1]
Centenial Surgical Suture, established in 1995, specializes in manufacturing surgical sutures in India.
The company offers a wide range of sutures including absorbable and non-absorbable types, supporting various surgical procedures.
Listed peers in Medical Equipment & Supplies: Shree Pacetronix Ltd, KMS Medisurgi Ltd, Amkay Products Ltd, GKB Ophthalmics Ltd, Galaxy Medicare Ltd, Transpact Enterprises Ltd.
Valuation & Returns
10 Jul 2026At ₹80.01 a share on 10 Jul 2026, Centenial Surgical Suture Ltd (CSURGSU) was valued at a price-to-book of 0.95x on a book value of ₹84.3 per share as of Mar 2025. Solomo computes return on equity of -7.19% and return on capital employed of 2.07% from filed results. Earnings ratios use standalone results for the twelve months Jun 2025 to Mar 2026.
- Industry P/E
- 44.11x
- P/B
- 0.95x
- EPS (TTM)
- ₹-6.06
- Book value / share
- ₹84.3
- ROE
- -7.19%
- ROCE
- 2.07%
- ROA
- -2.61%
- Debt / equity
- 0.98x
- Dividend yield
- 0%
- EBITDA margin
- 9.75%
- 52-week range
- ₹73.04 – ₹189
Ratios are computed from filed results and the last recorded price. Not investment advice.
Financial Performance
Mar 2026In the year ended Mar 2026, Centenial Surgical Suture Ltd (CSURGSU) reported revenue of ₹53.84 crore, net profit of ₹-2.2 crore and earnings per share of ₹-6.03. That compares with revenue of ₹53.49 crore and net profit of ₹-1.46 crore in Mar 2025. Figures are standalone, as filed with the exchanges.
In the quarter ended Mar 2026, revenue was ₹12.58 crore and net profit ₹-2.31 crore (standalone).
| Metric | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|
| Revenue (₹ cr) | 44.43 | 52.66 | 51.19 | 53.49 | 53.84 |
| Net profit (₹ cr) | 0.63 | 0.89 | 1.13 | -1.46 | -2.2 |
| EPS (₹) | 1.73 | 2.44 | 3.1 | -4 | -6.03 |
| Measure | 10Y | 5Y | 3Y | 1Y |
|---|---|---|---|---|
| Sales growth | -0.19% | -0.77% | 6.40% | 4.55% |
| Profit growth | - | - | - | -229.20% |
Ownership Summary
Jun 2026As of Jun 2026, promoters hold 46.89% of Centenial Surgical Suture Ltd (CSURGSU) (unchanged from the previous quarter). Market capitalisation was ₹29 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2001.
Largest disclosed public shareholders in Jun 2026: KARTIK SHYAM KINGAR 16.7%, DEVENDRA K. KOTHARI 9.46%, PARAG HIMATLAL SHETH 3.97%, BIRJU HARSHAD TANNA 3.19%, Independent Director or his relatives 1.27%, DHANRAJ RAJESH GALA 1.16%. Only stakes above the 1% disclosure threshold are named in filings.
| Quarter | Promoter | Pledged | FII | DII | Public |
|---|---|---|---|---|---|
| Jun 2026 | 46.89% | - | - | - | 53.11% |
| Mar 2026 | 46.89% | - | - | - | 53.11% |
| Dec 2025 | 46.89% | - | - | - | 53.11% |
| Sep 2025 | 46.89% | - | - | - | 53.11% |
| Jun 2025 | 46.89% | - | - | - | 53.11% |
| Mar 2025 | 46.89% | - | - | - | 53.11% |
| Dec 2024 | 46.89% | - | - | - | 53.11% |
| Sep 2024 | 46.89% | - | - | - | 53.11% |